表紙:構造的心疾患向けオクルーダー - 医療機器のパイプライン製品状況(2021年)
市場調査レポート
商品コード
1045755

構造的心疾患向けオクルーダー - 医療機器のパイプライン製品状況(2021年)

Structural Heart Occluders - Medical Devices Pipeline Product Landscape, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 86 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.31円
構造的心疾患向けオクルーダー - 医療機器のパイプライン製品状況(2021年)
出版日: 2021年12月07日
発行: GlobalData
ページ情報: 英文 86 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、構造的心疾患向けオクルーダーについて調査し、様々な開発段階にある製品の比較分析や、進行中の臨床試験に関する情報を含む、パイプライン製品に関する包括的な情報を提供しています。

目次

第1章 目次

  • 表のリスト
  • 図のリスト

第2章 イントロダクション

  • 構造的心疾患向けオクルーダーの概要

第3章 開発中の製品

  • 構造的心疾患向けオクルーダー - 開発段階別のパイプライン製品
  • 構造的心疾患向けオクルーダー - セグメント別のパイプライン製品
  • 構造的心疾患向けオクルーダー - 地域別のパイプライン製品
  • 構造的心疾患向けオクルーダー - 規制経路別のパイプライン製品
  • 構造的心疾患向けオクルーダー - 承認予定日別のパイプライン製品
  • 構造的心疾患向けオクルーダー - 進行中の臨床試験

第4章 構造的心疾患向けオクルーダー - 企業別:開発中のパイプライン製品

  • 構造的心疾患向けオクルーダー企業 - 開発段階別のパイプライン製品
  • 構造的心疾患向けオクルーダー - 開発段階別のパイプライン製品

第5章 構造的心疾患向けオクルーダー企業と製品概要

  • Aegis Medical Innovations Inc.の企業概要
  • Aporo Biomedical, Inc. (Inactive)の企業概要
  • Append Medicalの企業概要
  • atHeart Medicalの企業概要
  • AuriGen Medical Ltdの企業概要
  • Boston Scientific Corpの企業概要
  • CARAG AGの企業概要
  • Cierra, Inc. (Inactive)の企業概要
  • Conformal Medical Incの企業概要
  • Cor Habere Corpの企業概要
  • Dextera Surgical Incの企業概要
  • Ension, Inc.の企業概要
  • Hansen Medical Inc (Inactive)の企業概要
  • Laminar Incの企業概要
  • Lifetech Scientific (Shenzhen) Co Ltdの企業概要
  • LuSeed Vascularの企業概要
  • Mayo Clinicの企業概要
  • Medtronic Plcの企業概要
  • Meril Life Sciences Pvt Ltdの企業概要
  • Micro Interventional Devices, Inc.の企業概要
  • MicroPort Scientific Corpの企業概要
  • Northwestern Universityの企業概要
  • Occlutech International ABの企業概要
  • SentreHEART Incの企業概要
  • SeptRx, Inc. (Inactive)の企業概要
  • Shanghai HeartCare Medical Technology Co Ltdの企業概要
  • Sheba Medical Centerの企業概要
  • Shenzhen Salubris Pharmaceuticals Co Ltdの企業概要
  • Swissimplant AGの企業概要
  • University of Minnesotaの企業概要
  • Vascular Closure Systems Incの企業概要
  • Vascular Concepts Ltdの企業概要
  • W. L. Gore & Associates Incの企業概要

第6章 付録

  • 調査手法
  • GlobalDataについて
  • お問い合わせ
  • 免責事項
図表

List of Tables

Structural Heart Occluders - Pipeline Products by Stage of Development

Structural Heart Occluders - Pipeline Products by Segment

Structural Heart Occluders - Pipeline Products by Territory

Structural Heart Occluders - Pipeline Products by Regulatory Path

Structural Heart Occluders - Pipeline Products by Estimated Approval Date

Structural Heart Occluders - Ongoing Clinical Trials

Structural Heart Occluders Companies - Pipeline Products by Stage of Development

Structural Heart Occluders - Pipeline Products by Stage of Development

Glossary

List of Figures

Structural Heart Occluders - Pipeline Products by Stage of Development

Structural Heart Occluders - Pipeline Products by Segment

Structural Heart Occluders - Pipeline Products by Territory

Structural Heart Occluders - Pipeline Products by Regulatory Path

Structural Heart Occluders - Pipeline Products by Estimated Approval Date

Structural Heart Occluders - Ongoing Clinical Trials

目次
Product Code: GDME1287EPD

GlobalData's Medical Devices sector report, "Structural Heart Occluders - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Structural Heart Occluders under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Structural Heart Occluders under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Structural Heart Occluders Overview

3 Products under Development

  • 3.1 Structural Heart Occluders - Pipeline Products by Stage of Development
  • 3.2 Structural Heart Occluders - Pipeline Products by Segment
  • 3.3 Structural Heart Occluders - Pipeline Products by Territory
  • 3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
  • 3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
  • 3.6 Structural Heart Occluders - Ongoing Clinical Trials

4 Structural Heart Occluders - Pipeline Products under Development by Companies

  • 4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
  • 4.2 Structural Heart Occluders - Pipeline Products by Stage of Development

5 Structural Heart Occluders Companies and Product Overview

  • 5.1 Aegis Medical Innovations Inc. Company Overview
  • 5.2 Aporo Biomedical, Inc. (Inactive) Company Overview
  • 5.3 Append Medical Company Overview
  • 5.4 atHeart Medical Company Overview
  • 5.5 AuriGen Medical Ltd Company Overview
  • 5.6 Boston Scientific Corp Company Overview
  • 5.7 CARAG AG Company Overview
  • 5.8 Cierra, Inc. (Inactive) Company Overview
  • 5.9 Conformal Medical Inc Company Overview
  • 5.10 Cor Habere Corp Company Overview
  • 5.11 Dextera Surgical Inc Company Overview
  • 5.12 Ension, Inc. Company Overview
  • 5.13 Hansen Medical Inc (Inactive) Company Overview
  • 5.14 Laminar Inc Company Overview
  • 5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.16 LuSeed Vascular Company Overview
  • 5.17 Mayo Clinic Company Overview
  • 5.18 Medtronic Plc Company Overview
  • 5.19 Meril Life Sciences Pvt Ltd Company Overview
  • 5.20 Micro Interventional Devices, Inc. Company Overview
  • 5.21 MicroPort Scientific Corp Company Overview
  • 5.22 Northwestern University Company Overview
  • 5.23 Occlutech International AB Company Overview
  • 5.24 SentreHEART Inc Company Overview
  • 5.25 SeptRx, Inc. (Inactive) Company Overview
  • 5.26 Shanghai HeartCare Medical Technology Co Ltd Company Overview
  • 5.27 Sheba Medical Center Company Overview
  • 5.28 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
  • 5.29 Swissimplant AG Company Overview
  • 5.30 University of Minnesota Company Overview
  • 5.31 Vascular Closure Systems Inc Company Overview
  • 5.32 Vascular Concepts Ltd Company Overview
  • 5.33 W. L. Gore & Associates Inc Company Overview

6 Appendix

  • 6.1 Methodology
  • 6.2 About GlobalData
  • 6.3 Contact Us
  • 6.4 Disclaimer